Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Berchuck

Showing results (71-80 of 191) with videos related to

Pageof 20
Sort By:
Journal of the Society for Gynecologic Investigation|May 5, 2001
Relationship between expression of coactivators and corepressors of hormone receptors and resistance of ovarian cancers to growth regulation by steroid hormonesL J Havrilesky, C P McMahon, E K Lobenhofer, et al.
Obstetrics and Gynecology|September 11, 1990
Expression of epidermal growth factor receptor and HER-2/neu in normal and neoplastic cervix, vulva, and vaginaA Berchuck, G Rodriguez, A Kamel, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|December 1, 1994
Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cellsA Elbendary, A Berchuck, P Davis, et al.
American Journal of Obstetrics and Gynecology|March 1, 1991
Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. II. Relationship between receptor expression and response to epidermal growth factorG C Rodriguez, A Berchuck, R S Whitaker, et al.
Obstetrics and Gynecology|March 1, 1994
The negative prognostic implications of thrombocytosis in women with stage IB cervical cancerG C Rodriguez, D L Clarke-Pearson, J T Soper, et al.
Gynecologic Oncology|March 1, 1995
Etoposide-platin combination therapy for chemorefractory gestational trophoblastic diseaseJ T Soper, A C Evans, G Rodriguez, et al.
The American Journal of Pathology|March 1, 1995
Distribution of integrin cell adhesion molecules in endometrial cancerB A Lessey, S Albelda, C A Buck, et al.
Obstetrics and Gynecology|January 1, 1994
Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic diseaseJ T Soper, A C Evans, D L Clarke-Pearson, et al.
Gynecologic Oncology|January 1, 1990
Treatment of endometrial stromal tumorsA Berchuck, S C Rubin, W J Hoskins, et al.
Obstetrics and Gynecology|October 1, 1995
Relationship between race and interval to treatment in endometrial cancerJ R Liu, M Conaway, G C Rodriguez, et al.
Pageof 20

Showing results (71-80 of 191) with videos related to

Sort By:
Pageof 20
Journal of the Society for Gynecologic Investigation|May 5, 2001
Relationship between expression of coactivators and corepressors of hormone receptors and resistance of ovarian cancers to growth regulation by steroid hormonesL J Havrilesky, C P McMahon, E K Lobenhofer, et al.
Obstetrics and Gynecology|September 11, 1990
Expression of epidermal growth factor receptor and HER-2/neu in normal and neoplastic cervix, vulva, and vaginaA Berchuck, G Rodriguez, A Kamel, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|December 1, 1994
Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cellsA Elbendary, A Berchuck, P Davis, et al.
American Journal of Obstetrics and Gynecology|March 1, 1991
Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. II. Relationship between receptor expression and response to epidermal growth factorG C Rodriguez, A Berchuck, R S Whitaker, et al.
Obstetrics and Gynecology|March 1, 1994
The negative prognostic implications of thrombocytosis in women with stage IB cervical cancerG C Rodriguez, D L Clarke-Pearson, J T Soper, et al.
Gynecologic Oncology|March 1, 1995
Etoposide-platin combination therapy for chemorefractory gestational trophoblastic diseaseJ T Soper, A C Evans, G Rodriguez, et al.
The American Journal of Pathology|March 1, 1995
Distribution of integrin cell adhesion molecules in endometrial cancerB A Lessey, S Albelda, C A Buck, et al.
Obstetrics and Gynecology|January 1, 1994
Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic diseaseJ T Soper, A C Evans, D L Clarke-Pearson, et al.
Gynecologic Oncology|January 1, 1990
Treatment of endometrial stromal tumorsA Berchuck, S C Rubin, W J Hoskins, et al.
Obstetrics and Gynecology|October 1, 1995
Relationship between race and interval to treatment in endometrial cancerJ R Liu, M Conaway, G C Rodriguez, et al.
Pageof 20